IDT Launches Affordable Gene Fragments

IDT Launches Affordable Gene Fragments with Faster Turnaround and Next-Day Shipping

IDT Unveils Advanced Synthetic Biology Center and Gene Fragment Services Faster, Affordable, and Tailored DNA Solutions for Researchers Global genomics leader Integrated DNA Technologies (IDT) has officially launched a state-of-the-art Synthetic Biology Center dedicated to custom gene solutions. This expansion…

Read MoreIDT Launches Affordable Gene Fragments with Faster Turnaround and Next-Day Shipping
GLP Compliance Documentation & Recordkeeping

GLP Compliance Documentation & Recordkeeping Training (Online, July 28-29, 2025)

Comprehensive Training on GLP Compliance Documentation and Recordkeeping Now Available ResearchAndMarkets.com has recently introduced a new online seminar titled “GLP Laboratory Compliance Documentation and Recordkeeping” designed to equip laboratory professionals with the essential knowledge and skills needed to maintain rigorous…

Read MoreGLP Compliance Documentation & Recordkeeping Training (Online, July 28-29, 2025)
New Study Finds Health-Boosting Compounds

New Study Finds Health-Boosting Compounds in California Almonds

New Research Uncovers Powerful Health-Promoting Compounds in California Almonds New Research Uncovers Powerful Health-Promoting Compounds in California Almonds California almonds—already known for their heart-healthy and nutrient-rich profile—may be even more beneficial than previously thought. Brightseed, a pioneering company in nutritional…

Read MoreNew Study Finds Health-Boosting Compounds in California Almonds
Feinstein Institutes Study Noninvasive Bioelectronics

Feinstein Institutes Study Noninvasive Bioelectronics for Post-Surgery Blood Sugar Control

Feinstein Institutes Study Focused Ultrasound to Regulate Blood Sugar After Surgery Researchers and clinicians at Northwell Health’s Feinstein Institutes for Medical Research are breaking new ground in the field of bioelectronic medicine, exploring the use of focused ultrasound (FUS) to…

Read MoreFeinstein Institutes Study Noninvasive Bioelectronics for Post-Surgery Blood Sugar Control
NYB.AI and Pnaseer Partner to Advance

NYB.AI and Pnaseer Partner to Advance AI-Driven Hair Regeneration Research

NYB.AI and Pnaseer Form Strategic Alliance to Advance AI-Powered Hair Regeneration Research NYB.AI, a pioneer in AI-driven drug discovery, and Pnaseer Inc., a leader in bio-nanoparticle drug delivery technologies, have announced a strategic partnership to accelerate the discovery and development…

Read MoreNYB.AI and Pnaseer Partner to Advance AI-Driven Hair Regeneration Research
Agenus’ BOTBAL Shows 42% 2-Year Survival

Agenus’ BOT/BAL Shows 42% 2-Year Survival in MSS CRC, Moves Toward FDA Registration

Agenus’ BOT/BAL Combo Delivers 42% Two-Year Survival in MSS Colorectal Cancer: Phase 3 Trial Aligned with FDA Agenus Inc., a pioneer in immuno-oncology, announced compelling new clinical results and regulatory progress for its combination therapy of botensilimab and balstilimab (BOT/BAL).…

Read MoreAgenus’ BOT/BAL Shows 42% 2-Year Survival in MSS CRC, Moves Toward FDA Registration